Search Results
274 results found for "VIB-VUB Center for Structural Biology"
- 📰 GPCR Weekly News, August 14 to 20, 2023
Optogenetic manipulation of Gq- and Gi/o-coupled receptor signaling in neurons and heart muscle cells Structural and Molecular Insights into GPCR Function A method for structure determination of GPCRs in various states MPGPCR Conference (November 15 -17, 2023) ASCEPT Annual Scientific Meeting (November 20 -23, 2023) Structure
- 📰 GPCR Weekly News, April 1 to 7, 2024
GPCR Symposia Join us on June 7th for our next symposium on Structural and Molecular Insights into GPCR Phosphorylation and G-Protein Mediated Signaling Networks June 25 - 29, 2024 | FENS Forum 2024 October 2024 | Biologics
- 📰 GPCR Weekly News, September 25 to October 1, 2023
mechanism of traditional Chinese medicine in the treatment of glioblastoma multiforme Industry News Structure 2024 | Chemotactic Cytokines GPCR Jobs NEW In vivo Antibody Discovery Research Scientist NEW In Vitro Biologist
- Functional Characterization of the Venus Flytrap Domain of the Human TAS1R2 Sweet Taste Receptor
dichroism spectroscopic studies revealed that hTAS1R2-VFT was properly folded with evidence of secondary structures quantities of hTAS1R2-VFT to further characterize the mechanism of binding interaction and perform structural
- A Model for the Signal Initiation Complex Between Arrestin-3 and the Src Family Kinase Fgr
To provide a framework for this interaction, we determined the crystal structure of the Fgr SH3 domain Collectively, these studies provide a structural framework for arrestin-dependent activation of Fgr.
- On-cell nuclear magnetic resonance spectroscopy to probe cell surface interactions
spectroscopy allows the determination of atomic-level information on intermolecular interactions, molecular structure ligands involved in binding, ligand bound-state conformational determination, evaluation of receptor structuring
- 📰 GPCR Weekly News, October 30 to November 4, 2023
Study of G protein-coupled receptors dimerization: From bivalent ligands to drug-like small molecules Structural Orexin Receptor Antagonist for the Treatment of Insomnia OMass Therapeutics Releases First Protein Structures in PDB, Advances Lupus Therapy Research Structure Therapeutics Receives R&D Achievement of the Year
- Dual loss of regulator of G protein signaling 2 and 5 exacerbates ventricular myocyte arrhythmias...
Here we examined how the dual absence of RGS2 and 5 (Rgs2/5 dbKO) affects blood pressure and cardiac structure
- Cancer Research UK and Sosei Heptares sign agreement to advance cancer immunotherapy candidate ...
Company”; TSE: 4565), an international biopharmaceutical company and world-leader in GPCR1-focused structure-based
- Research Network on Signal Transduction (ERNEST) has established an Emergency Fund for Ukrainian ...
Researchers affiliated to any legal entity in Ukraine (for example, schools and universities, research centers
- Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
Dimensionality reduction analysis shows that Nb80 stabilizes structural features of the β2AR with an intracellular binding partners on the GPCR activation mechanism, which should be taken into account in structure-based
- The development of modulators for lysophosphatidic acid receptors: A comprehensive review
bioactive phospholipids implicated in a wide range of cellular activities that regulate a diverse array of biological While no drugs targeting LPARs have been approved by the FDA thus far, at least three antagonists have entered BMS-986278) and systemic sclerosis (SAR100842), and one radioligand (BMT-136088/18F-BMS-986327) has entered
- 📰 GPCR Weekly News, October 23 to 29, 2023
extracellular calcium pathways Versatile lactate signaling via HCAR1: a multifaceted GPCR involved in many biological vitro pharmacology - Crinetics Pharmaceuticals In vivo Antibody Discovery Research Scientist In Vitro Biologist
- Molecular insights into regulation of constitutive activity by RNA editing 5HT2C serotonin receptor
responsible for these effects of RNA editing, we present four active-state 5HT2C-transducer-coupled structures
- GPCR kinases generate an APH1A phosphorylation barcode to regulate amyloid-β generation
Collectively, these studies provide insight into the molecular and structural determinants of the APH1A-βarr2
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
2021 "Nov. 15, 2021 LONDON – There’s not yet proof of the pudding, but Omass Therapeutics Ltd.’s new structure-based
- 📰 GPCR Weekly News, April 15 to 21, 2024
GPCR Symposia Join us on June 7th for our symposium on Structural and Molecular Insights into GPCR Function Phosphorylation and G-Protein Mediated Signaling Networks June 25 - 29, 2024 | FENS Forum 2024 October 2024 | Biologics
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
Here, we review how nanobodies have been adopted to elucidate the structure, pharmacology, and signaling
- Fluorescent Ligands Targeting Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2
Here, we report the structure-based development of fluorescent ligands targeting the intracellular allosteric
- Opioid Receptors and Protonation-Coupled Binding of Opioid Drugs
In this review, we discuss the relationship between structure, function, and dynamics of opioid receptors
- Addex Therapeutics To Release Full-Year 2021 Financial Results And Host Conference Call On March 10
Tim Dyer, CEO, Roger Mills, CMO and Robert Lütjens, Head of Discovery Biology, will provide a business
- Odorant receptors – a bit of smell for drug discovery
Selective screening assays for ectopic ORs as well as investment on the structural characterization of function of ORs in vivo, development of in vitro systems for functional assays and the availability of structural information for structure-based drug design.
- Functional modulation of PTH1R activation and signaling by RAMP2
Employing homology modeling, we describe the putative structural molecular basis underlying our functional
- A broad look into the future of systemic sclerosis
The authors provide a hierarchical structure into the studies of the pathogenesis of SSc starting with
- New Resources in GPCRdb
present and demonstrate the newest resources of the GPCRdb: 1) the new G protein resources and 2) the structural
- Pepducin-mediated G Protein-Coupled Receptor Signaling in the Cardiovascular System
We will discuss the historic context of pepducin development for each receptor, as well as the structural
- Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of...
Structural and energetic analyses indicated that the palmitoylation of Go can allosterically stabilize
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
the Company Through the Next Stage of its Evolution "New team focused on expanding its GPCR-focused structure-based